arrow
M

Margaret L. Lind

Boston University School of Public Health
H指数:17
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study

第四剂新型冠状病毒肺炎疫苗对巴西40岁或以上成人严重新型冠状病毒肺炎的有效性: 一项基于人群的队列研究

2024-06-012
OAAI
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population

被监禁人群新型冠状病毒肺炎疫苗接种和SARS-CoV-2感染后出现渗漏保护的证据

2023-08-1913
OAAI
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil

具有同源和异源加强剂的灭活新型冠状病毒肺炎疫苗对巴西Omicron的有效性

2022-10-0664
OAAI
Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study

CoronaVac疫苗接种后新型冠状病毒肺炎风险随时间的变化: 测试阴性病例对照研究

2022-06-1310
OAAI
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
2022-06-0186
OAAI
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant
2020-11-1813
OAAI
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

衡量188国家与健康相关的可持续发展目标: 全球疾病负担研究2015的基线分析

LANCET
IF88.5
2016-10-01354
OAAI
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

全球,区域和国家的预期寿命,全因死亡率和249死因的原因特异性死亡率,1980 2015: 全球疾病负担研究2015的系统分析

LANCET
IF88.5
2016-10-013.7K
OAAI
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

1980至2015死产、新生儿、婴儿和5岁以下儿童死亡率的全球、区域、国家和选定的次国家水平: 全球疾病负担研究2015的系统分析

LANCET
IF88.5
2016-10-01559
OAAI